Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects

Journal of Experimental Medicine

Volumn 188, Issue 10, 1998, Pages 1955-1965

  Betz, Ulrich A K ^a,f   Bloch, Wilhelm ^a   Van Den Broek, Maries ^b   Yoshida, Kanji ^c   Taga, Tetsuya ^e   Kishimoto, Tadamitsu ^d   Addicks, Klaus ^a   Rajewsky, Klaus ^a   Müller, Werner ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c OSAKA UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f BAYER AG   (Germany)

Author keywords

Conditional gene targeting; Cre loxP technology; Gene targeting; Gp130; Gp130 dependent cytokines

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CYTOKINE; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M; RECEPTOR SUBUNIT;

ACUTE PHASE RESPONSE; ANIMAL TISSUE; ARTICLE; BLOOD DISEASE; GENE TARGETING; HEART DISEASE; IMMUNOPATHOLOGY; LIVER DISEASE; LUNG DISEASE; MOUSE; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINE RECEPTOR GP130; CYTOKINES; GENE TARGETING; HEMATOPOIETIC SYSTEM; HISTOCYTOCHEMISTRY; INTEGRASES; LIPOPOLYSACCHARIDES; LISTERIA MONOCYTOGENES; LIVER; LUNG; MEMBRANE GLYCOPROTEINS; MICE; MICROSCOPY, ELECTRON; PERIPHERAL NERVES; RECEPTORS, CYTOKINE; RECOMBINATION, GENETIC; VACCINIA VIRUS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL PROTEINS;

EID: 0032539008     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.10.1955     Document Type: Article

References (49)

1. Kishimoto, T., T. Taga, and S. Akira. 1994. Cytokine signal transduction. Cell. 76:253-262.
2. Taga, T., and T. Kishimoto. 1997. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:797-819.
3. Ichihara, M., T. Hara, H. Kim, T. Murate, and A. Miyajima. 1997. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Blood. 90:165-173.
4. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 368:339-342.
5. Stewart, C.L., P. Kaspar, L.J. Brunet, H. Bhatt, I. Gadi, F. Köntgen, and S.J. Abbondanzo. 1992. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 359:76-79.
6. Masu, Y., E. Wolf, B. Holtmann, M. Sendtner, G. Brem, and H. Thoenen. 1993. Disruption of the CNTF gene results in motor neuron degeneration. Nature. 365:27-32.
7. Nandurkar, H.H., L. Robb, D. Tarlinton, L. Barnett, F. Köntgen, and C.G. Begley. 1997. Adult mice with targeted mutation of the interleukin-11 receptor (IL11Rα) display normal hematopoiesis. Blood. 90:2148-2159.
8. Robb, L., R. Li, L. Hartley, H.H. Nandurkar, F. Köntgen, and C.G. Begley. 1998. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat. Med. 4:303-308.
9. Bernad, A., M. Kopf, R. Kulbacki, N. Weich, G. Koehler, and J.C. Gutierrez-Ramos. 1994. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity. 1:725-731.
10. Ramsay, A.J., A.J. Husband, I.A. Ramshaw, S. Bao, K.I. Matthaei, G. Koehler, and M. Kopf. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science. 264:561-563.
11. Dalrymple, S.A., L.A. Lucian, R. Slattery, T. McNeil, D.M. Aud, S. Fuchino, F. Lee, and R. Murray. 1995. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63:2262-2268.
12. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183:1345-1355.
13. Suzuki, Y., S. Rani, O. Liesenfeld, T. Kojima, S. Lim, T.A. Nguyen, S.A. Dalrymple, R. Murray, and J.S. Remington. 1997. Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect. Immun. 65:2339-2345.
14. Romano, M., M. Sironi, C. Toniatti, N. Polentarutti, P. Fruscella, P. Ghezzi, R. Faggioni, W. Luini, V. van Hinsbergh, S. Sozzani, et al. 1997. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:315-325.
15. Fattori, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. 1994. Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180:1243-1250.
16. Cressman, D.E., L.E. Greenbaum, R.A. De Angelis, G. Ciliberto, E.E. Furth, V. Poli, and R. Taub. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274:1379-1383.
17. Chai, Z., S. Gatti, C. Toniatti, V. Poli, and T. Bartfai. 1996. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1β: a study on IL-6-deficient mice. J. Exp. Med. 183: 311-316.
18. Klein, M.A., J.C. Moller, L.L. Jones, H. Bluethmann, G.W. Kreutzberg, and G. Raivich. 1997. Impaired neuroglial activation in interleukin-6 deficient mice. Glia. 19:227-233.
19. Poli, V., R. Balena, E. Fattori, A. Markatos, M. Yamamoto, H. Tanaka, G. Ciliberto, G.A. Rodan, and F. Costantini. 1994. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13:1189-1196.
20. Escary, J.L., J. Perreau, D. Dumenil, S. Ezine, and P. Brulet. 1993. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature. 363:361-364.
21. Ware, C.B., M.C. Horowitz, B.R. Renshaw, J.S. Hunt, D. Liggitt, S.A. Koblar, B.C. Gliniak, H.J. McKenna, T. Papayannopoulou, B. Thoma, et al. 1995. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development. 121:1283-1299.
22. Li, M., M. Sendtner, and A. Smith. 1995. Essential function of LIF receptor in motor neurons. Nature. 378:724-727.
23. De Chiara, T.M., R. Vejsada, W.T. Poueymirou, A. Acheson, C. Suri, J.C. Conover, B. Friedman, J. McClain, L. Pan, N. Stahl, et al. 1995. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell. 83:313-322.
24. Yoshida, K., T. Taga, M. Saito, S. Suematsu, A. Kumanogoh, T. Tanaka, H. Fujiwara, M. Hirata, T. Yamagami, T. Nakahata, et al. 1996. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA. 93:407-411.
25. Kawasaki, K., Y.H. Gao, S. Yokose, Y. Kaji, T. Nakamura, T. Suda, K. Yoshida, T. Taga, T. Kishimoto, H. Kataoka, et al. 1997. Osteoclasts are present in gp130-deficient mice. Endocrinology. 138:4959-4965.
26. Rajewsky, K., H. Gu, R. Kühn, U.A. Betz, W. Müller, J. Roes, and F. Schwenk. 1996. Conditional gene targeting. J. Clin. Invest. 98:600-603.
27. Broudy, V.C., N.L. Lin, N. Fox, T. Taga, M. Saito, and K. Kaushansky. 1996. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Blood. 88:2026-2032.
28. Roes, J., and K. Rajewsky. 1993. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J. Exp. Med. 177: 45-55.
29. Bachmann, M.F., T.M. Kundig, C.P. Kalberer, H. Hengartner, and R.M. Zinkernagel. 1993. Formalin inactivation of vesicular stomatitis virus impairs T-cell-but not T-help-independent B-cell responses. J. Virol. 67:3917-3922.
30. Gu, H., Y.R. Zou, and K. Rajewsky. 1993. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell. 73:1155-1164.
31. Betz, U.A., C.A. Vosshenrich, K. Rajewsky, and W. Müller. 1996. Bypass of lethality with mosaic mice generated by CreloxP-mediated recombination. Curr. Biol. 6:1307-1316.
32. Kühn, R., F. Schwenk, M. Aguet, and K. Rajewsky. 1995. Inducible gene targeting in mice. Science. 269:1427-1429.
33. Weber, H., D. Valenzuela, G. Lujber, M. Gubler, and C. Weissmann. 1987. Single amino acid changes that render human IFN-alpha 2 biologically active on mouse cells. EMBO J. 6:591-598.
34. Lin, Q., C. Dong, and M.D. Cooper. 1998. Impairment of T and B cell development by treatment with a type I interferon. J. Exp. Med. 187:79-87.
35. Sendtner, M., R. Gotz, B. Holtmann, J.L. Escary, Y. Masu, P. Carroll, E. Wolf, G. Brem, P. Brulet, and H. Thoenen. 1996. Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIF. Curr. Biol. 6:686-694.
36. Muraguchi, A., T. Hirano, B. Tang, T. Matsuda, Y. Horii, K. Nakajima, and T. Kishimoto. 1988. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167:332-344.
37. Sadlack, B., R. Kühn, H. Schorle, K. Rajewsky, W. Müller, and I. Horak. 1994. Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur. J. Immunol. 24:281-284.
38. Spriggs, M.K., B.H. Koller, T. Sato, P.J. Morissey, W.C. Fanslow, O. Smithies, R.F. Voice, M.B. Widmer, and C.R. Maliszewski. 1992. Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc. Natl. Acad. Sci. USA. 89:6070-6074.
39. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science. 259:1742-1745.
40. Ramsay, A.J., J. Ruby, and I.A. Ramshaw. 1993. A case for cytokines as effector molecules in the resolution of virus infection. Immunol.Today. 14:155-157.
41. Unanue, E.R. 1997. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol. Rev. 158:11-25.
42. Benigni, F., G. Fantuzzi, S. Sacco, M. Sironi, P. Pozzi, C.A. Dinarello, J.D. Sipe, V. Poli, M. Cappelletti, G. Paonessa, et al. 1996. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood. 87:1851-1854.
43. Barres, B.A., R. Schmid, M. Sendnter, and M.C. Raff. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development (Camb.). 118:283-295.
44. Wallace, P.M., J.F. MacMaster, J.R. Rillema, J. Peng, S.A. Burstein, and M. Shoyab. 1995. Thrombocytopoietic properties of oncostatin M. Blood. 86:1310-1315.
45. Suematsu, S., T. Matsuda, K. Aozasa, S. Akira, N. Nakano, S. Ohno, J. Miyazaki, K. Yamamura, T. Hirano, and T. Kishimoto. 1989. IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA. 86:7547-7551.
46. Travis, J., and G.S. Salvesen. 1983. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52:655-709.
47. Perlmutter, D.H., and J.A. Pierce. 1989. The alpha 1-antitrypsin gene and emphysema. Am. J. Physiol. 257:L147-L162.
48. Cichy, J., S. Rose-John, and J. Travis. 1998. Oncostatin M, leukaemia-inhibitory factor and interleukin 6 trigger different effects on alpha 1-proteinase inhibitor synthesis in human lung-derived epithelial cells. Biochem. J. 329:335-339.
49. Sallenave, J.M., G.M. Tremblay, J. Gauldie, and C.D. Richards. 1997. Oncostatin M, but not interleukin-6 or leukemia inhibitory factor, stimulates expression of alpha 1-proteinase inhibitor in A549 human alveolar epithelial cells. J. Interferon Cytokine Res. 17:337-346.